Neuroscience Antibodies and Assays Market, Trends & Analysis - Forecasts To 2025 By Product (Consumables, Instruments), By Technology (Immunoassay (Elisa), Molecular Diagnostics, Clinical Chemistry), By Application (Drug Discovery & Development , Research, IVD), By End User (Pharmaceutical & Biotechnology Companies , Academic & Research Institutes, Hospitals & Diagnostic Centers) , By Region (North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa); Vendor Landscape, and Company Market Share Analysis & Competitor Analysis - Global Market Estimates
Neuroscience Antibodies and Assays Market Insights
The Neuroscience Antibodies and Assays market is projected to grow at a high CAGR during the forecast period. The market is driven by growing investment in neuroscience research, high growth in the pharmaceutical and biotechnology industry and increasing investment in the field. Growing incidence of neurological diseases is also estimated to have a positive impact on the market during the forecast period. However, the high cost of these products and concerns with respect to their quality are some factors likely to hinder market growth up to a certain extent.
Neuroscience Antibodies and Assays Market: By Product
The Neuroscience Antibodies and Assays market can be segmented based on basis of product into consumables and instruments. The consumables segment is expected to hold the largest market share in terms of revenue and is also projected to grow at the highest CAGR during the forecast period. The consumables segment can be further classified into reagents, antibodies, and assays kits. Among these, the reagents segment is expected to hold the largest market share owing to the high consumption of reagents in multiple routine assays and techniques. Frequent purchases of consumables and Government initiatives in genomics and proteomics research are the major factors driving growth in the consumables segment during the forecast period.
Neuroscience Antibodies and Assays Market: By Technology
The Neuroscience Antibodies and Assays market can be segmented based on technology into immunoassays/immunochemistry, molecular diagnostics, and clinical chemistry among others. The immunoassays/immunochemistry segment is expected to grow at the highest CAGR during the forecast period and can be attributed to research and development activities in the domain
Neuroscience Antibodies and Assays Market: By Application
The Neuroscience Antibodies and Assays market can be segmented on the basis of application into drug discovery & development, research, and IVD among others. The drug discovery & development segment is expected to largest market share in terms of revenue owing to growing research and development expenditure.
Neuroscience Antibodies and Assays Market: By End User
The Neuroscience Antibodies and Assays market can be segmented into pharmaceutical and biotechnology companies, academic and research institutes, and hospitals and diagnostic centers among others. the pharmaceutical and biotechnology companies segment is expected to hold the largest market share in terms of revenue owing to the presence of large number of pharmaceutical players in the market and the high uptake of neuroscience antibodies in the drug discovery and development process.
Neuroscience Antibodies and Assays Market: Regional Insights
Asia is estimated to grow at the highest CAGR during the forecast period. The high growth can be attributed to favorable regulatory policies and the growing incidence of neurological diseases. These factors have generated numerous market opportunities for companies, which has led to a rise in the number of market players in the region. Further, rising investment in the life sciences sector is projected to further augment market growth.
Neuroscience Antibodies and Assays Market: End-Use Landscape
The end-use landscape entails a list of current and prospective consumers prevailing across the regions. This section provides company addresses, contact details, products, and regional presence of companies who are purchasing or are likely to purchase neuroscience antibodies and assays over the coming years. Some companies which are currently using neuroscience antibodies and assays and are likely to use in future are Roche, Novartis and Gilead Sciences among others.
Neuroscience Antibodies and Assays Market: Vendor Landscape
The report contains a chapter dedicated to vendors operating in the market, covering raw material manufactures, equipment developers, manufacturers, and distributors. The report provides these insights on a regional level. This section of the report entails contact details, experience, products manufactured/supplied, and geographical presence of companies.
Neuroscience Antibodies and Assays Market: Share & Competitor Analysis
Some of the key players operating in the Neuroscience Antibodies and Assays markets are Abcam, Thermo Fischer Scientific, Bio-Rad, Merck KGaA, Genscript, Cell Signaling Technology, Rockland Immunochemicals, BioLegend, Santa Cruz Biotechnology, Tecan, Siemens and F. Hoffmann-La Roche among others.
Please note: This is not an exhaustive list of companies profiled in the report.
On October 5, 2018, Piramal Pharma Solutions Announced the Launch of Xcelerate Integrated Solutions
In April 2018, Thermo Fischer Scientific announced its first cloud-enabled biological safety cabinet
In January 2018, Thermo Fischer Scientific expanded its oncomine profile
We value your investment and offer free customization with every report to fulfil your exact research needs.
The global Neuroscience Antibodies and Assays Market has been studied from the year 2016 till 2025. However, the CAGR provided in the report is from the year 2017 to 2025. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply side analysis for the Neuroscience Antibodies and Assays Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?